Regulators' Race for Transparency

ISSN： 1178-2595

Source： Pharmaceutical Medicine, Vol.23, Iss.4, 2009-08, pp. : 189-190

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulators of colon cancer angiogenesis

By Ahmad S.A. Shaheen R.M. Liu W. Jung Y.D. Takahashi Y. Akagi Y. Reinmuth N. Fan F. Ellis L.M.

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 3, 2000-06 ,pp. : 347-359

Informa Healthcare

Access to resources Recommend Favorite

Regulators of the anaphylatoxin C5a

By Taylor S.M. Fairlie D.P.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 4, 2000-04 ,pp. : 449-458

Informa Healthcare

Access to resources Recommend Favorite

Proteasome Regulators: Activators and Inhibitors

Current Medicinal Chemistry, Vol. 16, Iss. 8, 2009-03 ,pp. : 931-939

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondrial Lipids as Apoptosis Regulators

Current Medicinal Chemistry, Vol. 10, Iss. 16, 2003-08 ,pp. : 1573-1580

Bentham Science Publishers

Access to resources Recommend Favorite

Transparency in Economic Evaluations

By Hill Suzanne

PharmacoEconomics, Vol. 23, Iss. 10, 2005-01 ,pp. : 967-969

Adis International

Access to resources Recommend Favorite